Please assess the completion status of the following clinical trial:

Trial Title: Muscle-targeted Nutritional Therapy for the Recovery From COVID-19

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Sarcopenia (revised European Working Group on Sarcopenia in Older People criteria)~* Recent discharge from hospital for COVID-19~* Informed consent~Exclusion Criteria:~* Any malignant disease during the last five years~* Known kidney failure (previous glomerular filtration rate \<30 ml/min);~* Known liver failure (Child B or C)~* Psychiatric disease~* Endocrine disorders associated with disorders of calcium metabolism (excluding osteoporosis)~* Indications related to the study product:~More than 10 µg (400 IU) of daily Vitamin D intake from medical sources. More than 500 mg of daily calcium intake from medical sources. Adherence to a high energy or high protein diet up or use of protein containing or amino acid containing nutritional supplements up to three months before starting the study.~* Known allergy to milk, milk products or other components of the proposed interventions~* Indication to or ongoing artificial nutrition support~* Inclusion in other nutrition intervention trials~* Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements~* Refusal

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Muscle-target oral nutritional supplementation (Type: EXPERIMENTAL): Two servings (40 grams each) of powder (Fortifit; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, and 800 IU vitamin D

Based on this trial design, predict the completion outcome and termination type (if applicable).